Personalized vaccines for cancer immunotherapy von Sahin, Ugur, Türeci, Özlem

Volltext

mRNA-based therapeutics — developing a new class of drugs von Sahin, Ugur, Karikó, Katalin, Türeci, Özlem

Volltext

Identification of neoantigens for individualized therapeutic cancer vaccines von Lang, Franziska, Schrörs, Barbara, Löwer, Martin, Türeci, Özlem, Sahin, Ugur

Volltext

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study von Li, Jingxin, Hui, Aimin, Zhang, Xiang, Yang, Yumei, Tang, Rong, Ye, Huayue, Ji, Ruiru, Lin, Mei, Zhu, Zhongkui, Türeci, Özlem, Lagkadinou, Eleni, Jia, Siyue, Pan, Hongxing, Peng, Fuzhong, Ma, Zhilong, Wu, Zhenggang, Guo, Xiling, Shi, Yunfeng, Muik, Alexander, Şahin, Uğur, Zhu, Li, Zhu, Fengcai

Volltext

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents von Frenck, Robert W, Klein, Nicola P, Kitchin, Nicholas, Gurtman, Alejandra, Absalon, Judith, Lockhart, Stephen, Perez, John L, Walter, Emmanuel B, Senders, Shelly, Bailey, Ruth, Swanson, Kena A, Ma, Hua, Xu, Xia, Koury, Kenneth, Kalina, Warren V, Cooper, David, Jennings, Timothy, Brandon, Donald M, Thomas, Stephen J, Türeci, Özlem, Tresnan, Dina B, Mather, Susan, Dormitzer, Philip R, Şahin, Uğur, Jansen, Kathrin U, Gruber, William C

Volltext

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera von Muik, Alexander, Wallisch, Ann-Kathrin, Sänger, Bianca, Swanson, Kena A, Mühl, Julia, Chen, Wei, Cai, Hui, Maurus, Daniel, Sarkar, Ritu, Türeci, Özlem, Dormitzer, Philip R, Şahin, Uğur

Volltext

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera von Muik, Alexander, Lui, Bonny Gaby, Wallisch, Ann-Kathrin, Bacher, Maren, Mühl, Julia, Reinholz, Jonas, Ozhelvaci, Orkun, Beckmann, Nina, Güimil Garcia, Ramón de la Caridad, Poran, Asaf, Shpyro, Svetlana, Finlayson, Andrew, Cai, Hui, Yang, Qi, Swanson, Kena A, Türeci, Özlem, Şahin, Uğur

Volltext

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults von Mulligan, Mark J., Lyke, Kirsten E., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Raabe, Vanessa, Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Walsh, Edward E., Frenck, Robert, Falsey, Ann R., Dormitzer, Philip R., Gruber, William C., Şahin, Uğur, Jansen, Kathrin U.

Volltext

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates von Walsh, Edward E, Frenck, Robert W, Falsey, Ann R, Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J, Bailey, Ruth, Swanson, Kena A, Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R, Lyke, Kirsten E, Raabe, Vanessa, Dormitzer, Philip R, Jansen, Kathrin U, Şahin, Uğur, Gruber, William C

Volltext

Elimination of large tumors in mice by mRNA-encoded bispecific antibodies von Stadler, Christiane R, Bähr-Mahmud, Hayat, Celik, Leyla, Hebich, Bernhard, Roth, Alexandra S, Roth, René P, Karikó, Katalin, Türeci, Özlem, Sahin, Ugur

Volltext

Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening von Orlandini von Niessen, Alexandra G., Poleganov, Marco A., Rechner, Corina, Plaschke, Arianne, Kranz, Lena M., Fesser, Stephanie, Diken, Mustafa, Löwer, Martin, Vallazza, Britta, Beissert, Tim, Bukur, Valesca, Kuhn, Andreas N., Türeci, Özlem, Sahin, Ugur

Volltext

Targeting the tumor vasculature with engineered cystine-knot miniproteins von Lui, Bonny Gaby, Salomon, Nadja, Wüstehube-Lausch, Joycelyn, Daneschdar, Matin, Schmoldt, Hans-Ulrich, Türeci, Özlem, Sahin, Ugur

Volltext

Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years von Winokur, Patricia, Gayed, Juleen, Fitz-Patrick, David, Thomas, Stephen J., Diya, Oyeniyi, Lockhart, Stephen, Xu, Xia, Zhang, Ying, Bangad, Vishva, Schwartz, Howard I., Denham, Douglas, Cardona, Jose F., Usdan, Lisa, Ginis, John, Mensa, Federico J., Zou, Jing, Xie, Xuping, Shi, Pei-Yong, Lu, Claire, Buitrago, Sandra, Scully, Ingrid L., Cooper, David, Koury, Kenneth, Jansen, Kathrin U., Türeci, Özlem, Şahin, Uğur, Swanson, Kena A., Gruber, William C., Kitchin, Nicholas

Volltext

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines von Pather, Shanti, Madhi, Shabir A, Cowling, Benjamin J, Moss, Paul, Kamil, Jeremy P, Ciesek, Sandra, Muik, Alexander, Türeci, Özlem

Volltext

Racing for a SARS‐CoV‐2 vaccine von Türeci, Özlem, Şahin, Uğur

Volltext

Tumor vaccination using messenger RNA: prospects of a future therapy von Kreiter, Sebastian, Diken, Mustafa, Selmi, Abderraouf, Türeci, Özlem, Sahin, Ugur

Volltext

Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins von Beissert, Tim, Koste, Lars, Perkovic, Mario, Walzer, Kerstin C, Erbar, Stephanie, Selmi, Abderraouf, Diken, Mustafa, Kreiter, Sebastian, Türeci, Özlem, Sahin, Ugur

Volltext

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal... von Lordick, Florian, Al-Batran, Salah-Eddin, Ganguli, Arijit, Morlock, Robert, Sahin, Ugur, Türeci, Özlem

Volltext

The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis von Simon, Adrian Georg, Lyu, Su Ir, Laible, Mark, Wöll, Stefan, Türeci, üzlem, Åahin, UÄur, Alakus, Hakan, Fahrig, Luca, Zander, Thomas, Buettner, Reinhard, Bruns, Christiane Josephine, Schroeder, Wolfgang, Gebauer, Florian, Quaas, Alexander

Volltext

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data von van den Ouweland, Frank, Charpentier, Nicola, Türeci, Özlem, Rizzi, Ruben, Mensa, Federico J., Lindemann, Claudia, Pather, Shanti

Volltext